Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content
Fig. 4 | European Journal of Medical Research

Fig. 4

From: Glucocorticoids can reduce mortality in patients with severe community-acquired pneumonia: a systematic review and meta-analysis of randomized controlled trials

Fig. 4

Line graph showing trial sequential analysis for all-cause mortality in included randomized controlled trials. The uppermost and lowermost curves represent trial sequential monitoring boundary lines for benefit and harm, respectively. Horizontal lines represent traditional boundaries for statistical significance. The cumulative z-curve represents the trial data. The Z-curve crosses the boundaries of continuous monitoring and routine ineffectiveness in the experiment, indicating that although the sample size did not reach the required amount (n = 4780) of information, glucocorticoid has been shown to reduce the mortality rate of severe community-acquired pneumonia patients. TSA Trial Sequential Analysis

Back to article page